Merck's Drug Approved for Diarrhea Treatment in Children
January 27 2020 - 7:32AM
Dow Jones News
By Dave Sebastian
Merck & Co. (MRK) on Monday said the U.S. Food and Drug
Administration has approved its new drug application for Dificid
tablets to treat Clostridioides difficile-associated diarrhea in
children aged six months and older.
The approval was based on the company's phase 3 study that
involved 148 patients, Merck said.
Shares of Merck fell 0.73% in premarket trading.
Write to Dave Sebastian at dave.sebastian@wsj.com
(END) Dow Jones Newswires
January 27, 2020 07:17 ET (12:17 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
Merck (NYSE:MRK)
Historical Stock Chart
From Mar 2024 to Apr 2024
Merck (NYSE:MRK)
Historical Stock Chart
From Apr 2023 to Apr 2024
